Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cells | 12 | 2021 | 3387 | 0.710 |
Why?
|
Virus Integration | 7 | 2016 | 300 | 0.640 |
Why?
|
Leukemia Virus, Murine | 1 | 2016 | 117 | 0.600 |
Why?
|
RNA, Bacterial | 2 | 2012 | 394 | 0.480 |
Why?
|
Hematopoiesis | 2 | 2019 | 1989 | 0.440 |
Why?
|
HIV | 3 | 2016 | 1542 | 0.430 |
Why?
|
Gene Expression Profiling | 7 | 2021 | 9494 | 0.390 |
Why?
|
Lymph Nodes | 1 | 2021 | 3424 | 0.360 |
Why?
|
Viral Proteins | 1 | 2016 | 1959 | 0.350 |
Why?
|
Genome, Bacterial | 1 | 2012 | 786 | 0.300 |
Why?
|
Macrophages | 1 | 2021 | 5746 | 0.290 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 3991 | 0.280 |
Why?
|
Mycobacterium tuberculosis | 2 | 2012 | 1811 | 0.260 |
Why?
|
Genomics | 2 | 2018 | 5338 | 0.250 |
Why?
|
Moloney murine leukemia virus | 3 | 2013 | 140 | 0.250 |
Why?
|
Retroviridae | 3 | 2011 | 954 | 0.240 |
Why?
|
Antigens, CD34 | 4 | 2019 | 663 | 0.230 |
Why?
|
Genetic Engineering | 2 | 2018 | 943 | 0.220 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2021 | 20 | 0.210 |
Why?
|
Metal Ceramic Alloys | 1 | 2000 | 14 | 0.200 |
Why?
|
Genetic Vectors | 5 | 2018 | 3525 | 0.190 |
Why?
|
Crowns | 1 | 2000 | 145 | 0.180 |
Why?
|
Incisor | 1 | 2000 | 171 | 0.180 |
Why?
|
Esthetics, Dental | 1 | 2000 | 202 | 0.170 |
Why?
|
Dental Prosthesis Design | 1 | 2000 | 236 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2020 | 5128 | 0.150 |
Why?
|
Wiskott-Aldrich Syndrome | 2 | 2016 | 131 | 0.150 |
Why?
|
Algorithms | 1 | 2016 | 13761 | 0.140 |
Why?
|
Cell Lineage | 3 | 2019 | 2589 | 0.130 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2018 | 774 | 0.130 |
Why?
|
Cell Tracking | 1 | 2016 | 147 | 0.130 |
Why?
|
Nuclear Pore | 1 | 2015 | 71 | 0.130 |
Why?
|
Lymphocytes | 2 | 2021 | 2734 | 0.130 |
Why?
|
Cluster Analysis | 3 | 2016 | 2767 | 0.120 |
Why?
|
Likelihood Functions | 1 | 2016 | 1004 | 0.120 |
Why?
|
Terminal Repeat Sequences | 1 | 2013 | 76 | 0.120 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2013 | 160 | 0.110 |
Why?
|
Genome, Human | 4 | 2018 | 4466 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2168 | 0.110 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 2560 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2015 | 0.100 |
Why?
|
Respiratory System | 1 | 2014 | 549 | 0.100 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2010 | 183 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 3064 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10285 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2129 | 0.090 |
Why?
|
Open Reading Frames | 1 | 2012 | 833 | 0.080 |
Why?
|
Chromatin | 3 | 2015 | 2678 | 0.080 |
Why?
|
Conserved Sequence | 1 | 2012 | 1233 | 0.080 |
Why?
|
Sequence Deletion | 1 | 2013 | 1548 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3670 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2021 | 2718 | 0.080 |
Why?
|
Virus Replication | 1 | 2015 | 2565 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2748 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 1 | 2014 | 1263 | 0.070 |
Why?
|
Mice | 4 | 2021 | 80270 | 0.070 |
Why?
|
Staphylococcus aureus | 1 | 2014 | 1391 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2014 | 1134 | 0.070 |
Why?
|
Computational Biology | 3 | 2013 | 3564 | 0.070 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22636 | 0.070 |
Why?
|
Transplantation, Autologous | 2 | 2020 | 2072 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2013 | 5995 | 0.060 |
Why?
|
Lentivirus | 2 | 2018 | 534 | 0.060 |
Why?
|
Mutagenesis, Insertional | 2 | 2016 | 660 | 0.050 |
Why?
|
Animals | 5 | 2021 | 169173 | 0.050 |
Why?
|
Models, Genetic | 1 | 2011 | 3522 | 0.050 |
Why?
|
Post and Core Technique | 1 | 2000 | 20 | 0.050 |
Why?
|
Dental Porcelain | 1 | 2000 | 57 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2021 | 326 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 13171 | 0.050 |
Why?
|
Humans | 16 | 2021 | 715594 | 0.050 |
Why?
|
Transduction, Genetic | 2 | 2013 | 964 | 0.050 |
Why?
|
Color | 1 | 2000 | 308 | 0.040 |
Why?
|
Histones | 3 | 2013 | 2543 | 0.040 |
Why?
|
HIV-1 | 1 | 2015 | 6900 | 0.040 |
Why?
|
Surface Properties | 1 | 2000 | 1177 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1277 | 0.040 |
Why?
|
Blood Cells | 1 | 2018 | 318 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2021 | 778 | 0.040 |
Why?
|
Multipotent Stem Cells | 1 | 2016 | 198 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2431 | 0.030 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2015 | 164 | 0.030 |
Why?
|
Antibiosis | 1 | 2014 | 57 | 0.030 |
Why?
|
Terminator Regions, Genetic | 1 | 2012 | 26 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2015 | 778 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 11956 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2014 | 276 | 0.030 |
Why?
|
Luciferases | 1 | 2015 | 749 | 0.030 |
Why?
|
Clone Cells | 1 | 2016 | 1756 | 0.030 |
Why?
|
RNA, Antisense | 1 | 2012 | 140 | 0.030 |
Why?
|
Consensus Sequence | 1 | 2012 | 381 | 0.030 |
Why?
|
Genetic Loci | 2 | 2013 | 2613 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3248 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2015 | 572 | 0.030 |
Why?
|
5' Untranslated Regions | 1 | 2012 | 260 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2011 | 390 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 548 | 0.020 |
Why?
|
Virulence | 1 | 2014 | 1337 | 0.020 |
Why?
|
Biofilms | 1 | 2014 | 625 | 0.020 |
Why?
|
Species Specificity | 1 | 2014 | 2592 | 0.020 |
Why?
|
Adenosine Deaminase | 1 | 2011 | 242 | 0.020 |
Why?
|
Lymphocyte Depletion | 1 | 2010 | 635 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 2030 | 0.020 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2011 | 231 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3211 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 898 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4905 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4887 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2014 | 1334 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5369 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2012 | 1148 | 0.020 |
Why?
|
HLA Antigens | 1 | 2011 | 1545 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4263 | 0.020 |
Why?
|
Epigenomics | 1 | 2010 | 805 | 0.020 |
Why?
|
Stem Cells | 1 | 2018 | 3561 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1487 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1699 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19529 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2971 | 0.020 |
Why?
|
Fetal Blood | 1 | 2010 | 1323 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4635 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2010 | 4813 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 4035 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2010 | 6274 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12285 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4910 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2010 | 2810 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3423 | 0.010 |
Why?
|
Lung | 1 | 2014 | 9734 | 0.010 |
Why?
|
Transcription Factors | 1 | 2015 | 11942 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18175 | 0.010 |
Why?
|
Infant | 1 | 2016 | 34561 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19892 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 40889 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 41184 | 0.010 |
Why?
|
Male | 3 | 2016 | 350143 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23705 | 0.010 |
Why?
|
Adult | 1 | 2000 | 212237 | 0.000 |
Why?
|
Child | 1 | 2013 | 74413 | 0.000 |
Why?
|
Female | 1 | 2000 | 377052 | 0.000 |
Why?
|
Concepts
(140)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_